Evaluation of efficacy and tolerability of ioversol in intravenous urography. a comparative double-blind study versus iopamidol

Joffre, F.; Rousseau, H.; Aziza, R.

Annales de Radiologie 35(4 Part 2): 288-292

1992


ISSN/ISBN: 0003-4185
PMID: 1296494
Document Number: 403549
The efficacy and safety of Optiray (ioversol), a new low osmolar non-ionic contrast agent were compared with Iopamiron in a double-blind randomized trial for intravenous pyelography. Concerning the diagnostic efficacy, Optiray 300 was equivalent to Iopamiron 370 for identical injection volumes. Significantly less reinjections were necessary with Optiray. Tolerability was found to be excellent, equivalent to the reference product. Optiray was found to be both well tolerated and of satisfactory diagnostic value.

Document emailed within 1 workday
Secure & encrypted payments